ProteanFect represents a major leap forward in nucleic acid delivery. Unlike conventional lipid- or polymer-based reagents, ProteanFect harnesses mammalian endogenous proteins to deliver plasmid DNA ...
Trials-in-progress poster of ongoing pivotal Phase 3 trial of DNA-mediated immunotherapy accepted at both IGCS and ESMO Congress ...
Adeno-associated viruses (AAVs) have emerged in recent years as a crucial tool in clinical gene therapies, offering low pathogenicity and long-lived gene expression in target cells. AAVs are simple ...
This important study presents a thoughtful design and characterization of chimeric influenza hemagglutinin (HA) head domains combining elements of distinct receptor-binding sites. The results provide ...
IMNN-001, based on IMUNON’s proprietary TheraPlas ® technology platform, is an interleukin-12 (IL-12) DNA plasmid vector encased in a nanoparticle delivery system, enabling cell transfection followed ...
According to SNS Insider, the global Plasmid Purification Market was valued at USD 1.96 billion in 2024 and is expected to reach USD 4.74 billion by 2032, growing at a CAGR of 11.67% during the ...
Austin, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Transfection Reagents & Equipment Market Size & Growth Analysis: According to SNS Insider, the global Transfection Reagents & Equipment Market was valued at ...
A study conducted by a multinational research group investigated the potential of audible sound waves (in the form of music, specifically Pink Floyd’s "Another Brick in the Wall, Part 1") in enhancing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback